Prof Kaylene Simpson
Honorary Conjoint Professorial Fellow
The Sir Peter MacCallum Department of Oncology
189 Scholarly works
16 Projects
HIGHLIGHTS
2026
Journal article
Identifying therapeutic targets in low-grade serous ovarian carcinomas with no specific molecular profile
DOI: 10.1002/path.700752026
Journal article
From complexity to clarity: Building dashboards for hit selection in high throughput screens.
DOI: 10.1016/j.slasd.2026.1003242026
Journal article
Abstract A009: Integrating HER2-Targeted Antibody-Drug Conjugates into Mucinous Ovarian Cancer Treatment: A preclinical Assesstment
DOI: 10.1158/1538-7445.rareca26-a0092026
Journal article
A scalable, multi-resolution consensus clustering approach for prioritizing robust signals from high-throughput screens
DOI: 10.1093/bib/bbag2422022
Research grants (ARC, NHMRC, MRFF)
Establishment of Novel, Neuronal-Cell Based, Therapeutic Screens for Alzheimer\2019s Disease Using Patients Stem Cells
2020
Research grants (ARC, NHMRC, MRFF)
High Throughput Discovery of Synergistic Drug Combinations for Patients With Low-Grade Serous Ovarian Cancer
2020
Research Grant
Translating Patient Stem Cells Into Personalised Screens for Age-Related Macular Degeneration
RECENT SCHOLARLY WORKS
2026
Journal article
Abstract LB476: Combined inhibition of transcription initiation and histone deacetylation triggers blood cancer cell death
DOI: 10.1158/1538-7445.am2026-lb4762026
Journal article
Abstract 601: Translational reprogramming disrupts mitosis to drive SMAD4-deficient esophageal adenocarcinoma.
DOI: 10.1158/1538-7445.am2026-6012026
Journal article
Discovery and Characterization of VPRBP/DCAF1 Kinase Inhibitor Analogs as Microtubular Destabilizing Agents with Potent Antimyeloma Activity
DOI: 10.1158/1535-7163.MCT-25-03062026
Journal article
Differential Preclinical Efficacy of Combined CDK4/6 and MEK Inhibition in Low-Grade Serous Ovarian Carcinoma Based on KRAS/NF1 Mutational Status
DOI: 10.3390/ijms270417742026
Journal article
RAD54L coordinates the nucleolar DNA damage response to maintain rDNA stability
DOI: 10.1038/s44318-026-00864-32025
Other
Figure S1 from Distinct Assemblies of Heterodimeric Cytokine Receptors Govern Stemness Programs in Leukemia
DOI: 10.1158/2159-8290.30859587
RECENT PROJECTS
2024
Research grants (ARC, NHMRC, MRFF)
OMIX3: High-Capacity Integrated Multi-Omics
2023
Research grants (ARC, NHMRC, MRFF)
Repurposing Clinical Grade Medications for Treatment of Friedrich Ataxia Heart Disease